Skip to main content
Home
  • ALL Specialities ALL Specialities
    Home
    Home

    Neil Osterweil

    News

    Older Patients With COPD at Increased Risk for PE-Associated Death

    Author:
    Neil Osterweil
    Publish date: November 4, 2024

    Patients with COPD are at increased risk for fatal PE and may require targeted thromboprophylaxis.

    • Read More

    News

    AF Burden Increases Around Time of COPD Hospitalizations

    Author:
    Neil Osterweil
    Publish date: November 4, 2024

    Patients with COPD exacerbations requiring hospitalization should be monitored for cardiac arrhythmias.

    • Read More

    News

    Patients With Chronic Cough Report Relief With Semen Strychni

    Author:
    Neil Osterweil
    Publish date: October 31, 2024

    The strychnine containing medication is thought to have beneficial effects against cough associated with idiopathic interstitial pneumonia with...

    • Read More

    News

    Trend Toward Higher Mortality in Patients With CF and CVD

    Author:
    Neil Osterweil
    Publish date: October 9, 2024

    As patients with CF live into adulthood, they must now contend with health issues associated with aging, including CVD.

    • Read More

    News

    ‘Door-to-Thrombectomy’ Time for Acute PE Linked to Better Outcomes

    Author:
    Neil Osterweil
    Publish date: October 9, 2024

    Faster treatment with mechanical thrombectomy for patients with PE leads to better outcomes, research finds.

    • Read More

    News

    Promise for Disease-Modifying Therapies to Tame Huntington’s Disease

    Author:
    Neil Osterweil
    Publish date: September 30, 2024

    Much progress has been made in managing the symptoms of Huntington’s disease, but the real excitement lies in the development of DMARDs.

    • Read More

    News

    Ensifentrine for COPD: Out of reach for many?

    Author:
    Neil Osterweil
    Publish date: September 4, 2024

    At a planned annual wholesale cost of more than $35,000, the novel therapy may be out of financial reach for many patients, analysts caution.

    • Read More

    News

    Could This COPD Treatment’s Cost Put It Out of Reach for Many?

    Author:
    Neil Osterweil
    Publish date: August 15, 2024

    Newly approved COPD treatment may be promising, but its cost may be too much for many patients.

    • Read More

    News

    Cost of Drugs Can Be Breathtaking for COPD Patients

    Author:
    Neil Osterweil
    Publish date: July 19, 2024

    A recent cross-sectional study showed that nearly one in six patients in the United States reported missing a COPD drug dose, lowering the dose,...

    • Read More

    News

    Catch-and-Treat Strategy Identifies Undiagnosed Asthma and COPD

    Author:
    Neil Osterweil
    Publish date: May 30, 2024

    Community-focused study using spirometry data can help find undiagnosed COPD and asthma.

    • Read More

    News

    Diet and exercise improve cardiac function, QoL in PAH

    Author:
    Neil Osterweil
    Publish date: May 29, 2024

    A 12-week lifestyle intervention benefited patients with pulmonary arterial hypertension in a randomized controlled trial.

    • Read More

    News

    Hold the antianaerobics in the ICU whenever possible

    Author:
    Neil Osterweil
    Publish date: May 28, 2024

    Empiric use of anti-anaerobic antibiotics haw been consistently associated with worse outcomes in patients with sepsis.

    • Read More

    News

    Space: The final frontier of public health, air pollution data

    Author:
    Neil Osterweil
    Publish date: May 24, 2024

    National satellite-based systems provide data on air pollution and its components that can impact respiratory health.

    • Read More

    News

    Debate on pulmonary safety of gas stoves: Is the risk just hot air?

    Author:
    Neil Osterweil
    Publish date: May 22, 2024

    Indoor pollution from gas stoves can exacerbate asthma and COPD, but it’s still unclear whether it can cause COPD.

    • Read More

    News

    Novel ENV-101 associated with improved lung function in IPF

    Author:
    Neil Osterweil
    Publish date: May 21, 2024

    The Hedgehog pathway signaling inhibitor ENV-101 blocks wound repair signals that can lead to lung fibrosis and scarring, and may allow remodeling...

    • Read More

    Pages

    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • …
    • last »

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2024 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    • All Specialties
      • MDedge Home
      • Cardiology
      • Clinician Reviews
      • Dermatology
      • Emergency Medicine
      • Endocrinology/Diabetes
      • Family Medicine
      • Federal Practitioner
      • Gastroenterology
      • Hematology/Oncology
      • Infectious Disease
      • Internal Medicine
      • Neurology
      • Obstetrics And Gynecology
      • Pediatrics
      • Psychiatry
      • Pulmonology
      • Rheumatology
      • Surgery
    • MDedge Home
    • Cardiology
    • Clinician Reviews
    • Dermatology
    • Emergency Medicine
    • Endocrinology/Diabetes
    • Family Medicine
    • Federal Practitioner
    • Gastroenterology
    • Hematology/Oncology
    • Infectious Disease
    • Internal Medicine
    • Neurology
    • Obstetrics And Gynecology
    • Pediatrics
    • Psychiatry
    • Pulmonology
    • Rheumatology
    • Surgery